Table 1.
Enrollment sociodemographics and clinic characteristics of the comparison groups.
| Variable | Pre-cap group (n = 4714), n (%) | Cap group (n = 4295), n (%) | P value |
|---|---|---|---|
| Sex | |||
| Male | 1849 (39.2) | 1741 (40.5) | 0.212 |
| Female | 2865 (60.8) | 2554 (59.5) | |
| Missing | 0 (0) | 0 (0) | |
|
| |||
| Agea | |||
| Median | 37.0 | 36.9 | 0.255 |
| IQR | 31.0–44.1 | 30.6–44.0 | |
| Missing | 0 (0) | 0 (0) | |
|
| |||
| Clinic locationa | |||
| Urban | 2315 (49.1) | 2176 (50.7) | 0.146 |
| Rural | 2399 (50.9) | 2119 (49.3) | |
| Missing | 0 (0) | 0 (0) | |
|
| |||
| Travel time to clinica | |||
| <30 minutes | 1093 (23.4) | 962 (23.1) | 0.100 |
| 30–60 minutes | 1467 (31.5) | 1400 (33.6) | |
| 1-2 hours | 1266 (27.2) | 1127 (27.0) | |
| >2 hours | 836 (17.9) | 683 (16.4) | |
| Missing | 52 (1.1) | 123 (2.9) | |
|
| |||
| WHO clinical stagea | |||
| I | 637 (15.1) | 533 (14.5) | 0.780 |
| II | 839 (19.8) | 754 (20.6) | |
| III | 2278 (53.9) | 1977 (54.0) | |
| IV | 476 (11.3) | 400 (10.9) | |
| Missing | 484 (10.3) | 631 (14.7) | |
|
| |||
| CD4a | |||
| Median | 99.0 | 94.0 | 0.081 |
| IQR | 41.0–163 | 38.0–161 | |
| Missing | 59 (1.3) | 49 (1.1) | |
|
| |||
| Use of Cotrimoxazole or Dapsone | |||
| Yes | 3851 (81.7) | 3282 (76.4) | <0.001 |
| No | 863 (18.3) | 1013 (23.6) | |
| Missing | 0 (0) | 0 (0) | |
|
| |||
| TB treatmenta | |||
| Yes | 1180 (25.0) | 1121 (26.1) | 0.246 |
| No | 3534 (75.0) | 3174 (73.9) | |
| Missing | 0 (0) | 0 (0) | |
aAt Enrollment.